The Delhi Drugs Control Department has uncovered a significant counterfeit drugs racket involving Rosuvas F 20 tablets, a key medication for managing cholesterol and triglyceride levels, following a complaint from Sun Pharmaceutical Industries Ltd.. The department conducted raids across various locations in Delhi, resulting in the seizure of 1,800 spurious tablets worth Rs 88,000.

Key highlights:

• Complaint from Sun Pharma:

The company raised an alarm about counterfeit Rosuvas F 20 tablets being circulated by multiple wholesalers and distributors.

• Raids conducted:

On June 14 and 15, raids were carried out in Okhla and Bhagirath Palace, two prominent markets in Delhi, where counterfeit products were found.

• Suspicious stock:

Officials noted significant discrepancies in the appearance and packaging of the tablets when compared to the genuine product.

• Further investigation:

Seized samples were sent to government laboratories for quality testing, and manufacturer verification is underway.

• Legal action:

Custody of the seized drugs has been secured via the Delhi High Court, and investigations are ongoing to trace the entire supply chain behind these counterfeit medicines.This crackdown underscores the Delhi Drugs Control Department’s commitment to tackling the spread of counterfeit drugs, with Rosuvas F 20 tablets playing a crucial role in preventing serious cardiovascular diseases. Further action is expected as the department collaborates with authorities across other states to address this growing issue.